Garry Menzel
Director/Board Member at ADAPTIMMUNE THERAPEUTICS PLC
Net worth: 1 M $ as of 2024-04-29
Profile
Dr. Garry E.
Menzel is an Operating Partner at GHO Capital Partners LLP, an Independent Non-Executive Director at Adaptimmune Therapeutics Plc, an Independent Director at Stoke Therapeutics, Inc., an Independent Director at Black Diamond Therapeutics, Inc., a Member-National Board at Epilepsy Foundation and a Principal at Royal College of Art.
He is on the Board of Directors at Adaptimmune Therapeutics Plc, Stoke Therapeutics, Inc., Black Diamond Therapeutics, Inc. and Epilepsy Therapy Project.
Dr. Menzel was previously employed as a Chief Executive Officer by TCR2 Therapeutics, Inc., a Chief Strategy Officer by Pronutria Biosciences, Inc., a Chief Financial Officer by DaVita HealthCare Partners, Inc., a Chief Operating Officer by Regulus Therapeutics, Inc., a Managing Director by Credit Suisse Group, a Managing Director by The Goldman Sachs Group, Inc., a Consultant by Bain & Co., Inc., a Director-Emeritus by Institute for Systems Biology, and a Research Assistant by Smithkline Beecham Plc.
He received his undergraduate degree from Imperial College London, an MBA from Stanford Graduate School of Business and a doctorate degree from the University of Cambridge.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-31 | 3,667,344 ( 0.65% ) | 648 020 $ | 2024-04-29 | |
| 2024-04-04 | 76,664 ( 0.15% ) | 391 753 $ | 2024-04-29 | |
STOKE THERAPEUTICS, INC.
-.--% | 2024-03-30 | 0 ( -.--% ) | - $ | 2024-04-29 |
Garry Menzel active positions
| Companies | Position | Start |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Director/Board Member | 2013-12-31 |
| STOKE THERAPEUTICS, INC. | Director/Board Member | 2020-08-12 |
| ADAPTIMMUNE THERAPEUTICS PLC | Director/Board Member | 2023-05-31 |
Epilepsy Foundation
 Epilepsy Foundation Miscellaneous Commercial ServicesCommercial Services Epilepsy Foundation provides welfare services. It offers therapies to stop seizures, wellness institute and legal issue services. The company was founded in 1967 and is headquartered in Landover, MD. | Corporate Officer/Principal | 2002-12-31 |
| Epilepsy Therapy Project | Director/Board Member | - |
| Royal College of Art | Corporate Officer/Principal | 2010-03-16 |
GHO Capital Partners LLP
 GHO Capital Partners LLP Investment ManagersFinance GHO Capital Partners LLP (GHO Capital Partners) is a private equity firm founded in 2014 by Mireille G. Gillings, Dennis B. Gillings, Alan Browning MacKay, Michael Irvine Mortimer and Andrea Ponti. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 2024-04-22 |
Former positions of Garry Menzel
| Companies | Position | End |
|---|---|---|
| TCR2 THERAPEUTICS INC. | Chief Executive Officer | 2022-12-31 |
| AXCA HEALPAR | Corporate Officer/Principal | 2016-08-31 |
| ░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Garry Menzel
| Imperial College London | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
| University of Cambridge | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 7 |
|---|---|
| REGULUS THERAPEUTICS INC. | Health Technology |
| THE GOLDMAN SACHS GROUP, INC. | Finance |
| DAVITA INC. | Health Services |
| BLACK DIAMOND THERAPEUTICS, INC. | Health Technology |
| AXCA HEALPAR | Health Technology |
| STOKE THERAPEUTICS, INC. | Health Technology |
| ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
| Private companies | 8 |
|---|---|
Bain & Co., Inc.
 Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA. | Commercial Services |
Institute for Systems Biology
 Institute for Systems Biology Miscellaneous Commercial ServicesCommercial Services Institute for Systems Biology operates as a nonprofit biomedical research organization. It develops a systems approach to characterize, predict, and manipulate state transitions in biological system. The company was founded by Leroy E. Hood, Ruedi Aebersold and Alan Aderem in 2000 and is headquartered in Seattle, WA. | Commercial Services |
Credit Suisse Group AG
 Credit Suisse Group AG Investment Banks/BrokersFinance Credit Suisse Group AG is a holding company, which engages in the provision of financial services. It operates through the following four divisions: Wealth Management, Investment Bank, Swiss Bank and Asset Management and four geographic regions: Switzerland, Europe, the Middle East and Africa (EMEA), Asia Pacific, and Americas. The Wealth Management division offers comprehensive wealth management and investment solutions, tailored financing, and advisory services to ultra-high-net-worth (UHNW) and high net-worth (HNW) individuals and external asset managers. The Investment Bank division offers a broad range of financial products and services focused on client-driven businesses and also supports Credit Suisse’s Wealth Management division and its clients. The Swiss Bank division offers comprehensive advice and a wide range of financial solutions to private, corporate, and institutional clients in Switzerland. The Asset Management division offers investment solutions and services globally to a broad range of clients, including pension funds, governments, foundations and endowments, corporations, and individuals. The company was founded by Alfred Escher on July 5, 1856 and is headquartered in Zurich, Switzerland. | Finance |
| Epilepsy Therapy Project | |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
Epilepsy Foundation
Epilepsy Foundation Miscellaneous Commercial ServicesCommercial Services Epilepsy Foundation provides welfare services. It offers therapies to stop seizures, wellness institute and legal issue services. The company was founded in 1967 and is headquartered in Landover, MD. | Commercial Services |
GHO Capital Partners LLP
GHO Capital Partners LLP Investment ManagersFinance GHO Capital Partners LLP (GHO Capital Partners) is a private equity firm founded in 2014 by Mireille G. Gillings, Dennis B. Gillings, Alan Browning MacKay, Michael Irvine Mortimer and Andrea Ponti. The firm is headquartered in London, United Kingdom. | Finance |
- Stock Market
- Insiders
- Garry Menzel
